How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/zopiclone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Imovane — Competitive Intelligence Brief

Imovane (ZOPICLONE) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: zopiclone. Area: Neuroscience.

marketed zopiclone GABA A receptor alpha-5/beta-2/gamma-2 Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Imovane (ZOPICLONE) — Sunovion Pharms Inc.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Imovane TARGET	ZOPICLONE	Sunovion Pharms Inc	marketed	zopiclone	GABA A receptor alpha-5/beta-2/gamma-2	2004-01-01
Versed	Midazolam Hydrochloride	Takeda Pharmaceutical Company Limited	marketed	Benzodiazepine	GABA A receptor alpha-5/beta-2/gamma-2	1985-01-01
Byfavo	Byfavo	Chungbuk National University Hospital	marketed		GABA A receptor alpha-2/beta-2/gamma-2, GABA A receptor alpha-3/beta-2/gamma-2, GABA A receptor alpha-5/beta-2/gamma-2
Lunesta	ESZOPICLONE	Waylis	marketed	eszopiclone	Gamma-aminobutyric acid receptor subunit alpha-1	2004-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2028-01-18 — Versed · 9687495 · Formulation · US
2028-01-18 — Versed · 9289432 · Formulation · US
2028-01-18 — Versed · 8217033 · Formulation · US
2028-01-18 — Versed · 8809322 · Formulation · US
2038-06-20 — Versed · 10966990 · Formulation · US

Sponsor landscape (zopiclone class)

Sunovion Pharms Inc · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Imovane — Competitive Intelligence Brief. https://druglandscape.com/ci/zopiclone. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab